Reprogram Biosciences
PrivateLast Round
Seed
May 27, 2026
Total Funding Raised
$6M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Reprogram Biosciences is a biotechnology company that develops mRNA-based therapeutics that reprogram tumor cells to activate the immune system, with a focus on treating solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reprogram Biosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Reprogram Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 27, 2026 |
Key People
Founding team and executive leadership
Reprogram Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Narya Capital | Seed |
| 1517 Fund | Seed |
| Unshackled Ventures | Seed |
| Narya | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
$6M raised from 1517 Fund, Narya, and Unshackled Ventures.
Reprogram Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Reprogram Biosciences's valuation, stock price, and market status.